Citation: | XIE Jing, FAN Chunlin, XU Jie, ZHANG Jian, YE Wencai, ZHANG Xiaoqi. Alkaloids of Ervatamia pandacaqui[J]. Journal of China Pharmaceutical University, 2021, 52(3): 287-292. DOI: 10.11665/j.issn.1000-5048.20210304 |
[1] |
. Beijing:Science Press,1977:114.
|
[2] |
Li BT,Chen XM. Comparative reviewon apocynaceae in flora reipublicae popularis sinicae and flora of China[J]. Guihaia(广西植物),1997,17(4):299-305.
|
[3] |
Liu ZW,Yang TT,Wang WJ,et al. Ervahainine A,a new cyano-substituted oxindole alkaloid from Ervatamia hainanensis[J]. Tetrahedron Lett,2013,54(48):6498-6500.
|
[4] |
Tang BQ,Wang WJ,Huang XJ,et al. Iboga-type alkaloids from Ervatamia officinalis[J]. J Nat Prod,2014,77(8):1839-1846.
|
[5] |
Liu ZW,Huang XJ,Xiao HL,et al. New iboga-type alkaloids from Ervatamia hainanensis[J]. RSC Adv,2016,6(36):30277-30284.
|
[6] |
Liu ZW,Tang BQ,Zhang QH,et al. Ervaoffines E-G,three iboga-type alkaloids featuring ring C cleavage and rearrangement from Ervatamia officinalis[J]. RSC Adv,2017,7(35):21883-21889.
|
[7] |
Zhang QH,Ding Y,Bai WX,et al. Studies on alkaloids from Ervatamia pandacaqui[J]. China J Chin Mater Med(中国中药杂志),2018,43(7):1471-1475.
|
[8] |
Liu ZW,Zhang J,Li ST,et al. Ervadivamines A and B,two unusual trimeric monoterpenoid indole alkaloids from Ervatamia divaricata[J]. J Org Chem,2018,83(17):10613-10618.
|
[9] |
Kam TS,Loh KY,Wei C. Conophylline and conophyllidine:new dimeric alkaloids from Tabernaemontana divaricata[J]. J Nat Prod,1993,56(11):1865-1871.
|
[10] |
Kam TS,Pang HS,Choo YM,et al. Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata[J]. Chem Biodivers,2004,1(4):646-656.
|
[11] |
Kam TS,Sim KM. Five new iboga alkaloids from Tabernaemontana corymbosa[J]. J Nat Prod,2002,65(5):669-672.
|
[12] |
Achenbach H,Benirschke M,Torrenegra R. Alkaloids and other compounds from seeds of Tabernaemontana cymosa[J]. Phytochemistry,1997,45(2):325-335.
|
[13] |
Clivio P,Richard B,Hadi HA,et al. Alkaloids from leaves and stem bark of Ervatamia polyneura[J]. Phytochemistry,1990,29(9):3007-3011.
|
[14] |
Kam TS,Yoganathan K,Mok SL. Aspidofractinine alkaloids from Kopsia teoi[J]. Phytochemistry,1997,46(4):789-792.
|
[15] |
He YL,Chen WM,Feng XZ. Studies on chemical constituents of Longzhou Shancheng(Melodinus morsei)[J]. Chin Tradit Herbal Drugs(中草药),1993,24(12):623-625,670.
|
[16] |
Azoug M,Loukaci A,Richard B,et al. Alkaloids from stem bark and leaves of Peschiera buchtieni[J]. Phytochemistry,1995,39(5):1223-1228.
|
[17] |
Luo XG,Chen HS,Liang S,et al. Alkaloids from stems of Ervatamia yunnanensis[J]. Chin Chem Lett,2007,18(6):697-699.
|
[1] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[2] | WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902 |
[3] | YU Zexuan, JU Caoyun, ZHANG Can. Construction and application of gene delivery systems for primary dendritic cells[J]. Journal of China Pharmaceutical University, 2021, 52(4): 438-446. DOI: 10.11665/j.issn.1000-5048.20210406 |
[4] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[5] | ZHAO Yuekui, TANG Shanshan, ZHANG Yanfeng, ZONG Li, JIN Liang. Engineered mesenchymal stem cells as targeting therapeutic carriers in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(2): 134-139. DOI: 10.11665/j.issn.1000-5048.20160202 |
[6] | ZHANG Zhiqing, WANG Fang, ZHOU Ting, ZHANG Guodong, WANG Xiufeng, LI Yunze. A DNA polyaptamer system as a targeted antitumor drug delivery[J]. Journal of China Pharmaceutical University, 2015, 46(4). DOI: 10.11665/j.issn.1000-5048.20150408 |
[7] | SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103 |
[8] | JIANG Hulin. Biocompatible polymers for gene delivery in cancer gene therapy[J]. Journal of China Pharmaceutical University, 2013, 44(5): 476-481. DOI: 10.11665/j.issn.1000-5048.20130518 |
[9] | LI Ying-huan, ZONG Li, ZHU Jia-bi. Formulation optimization of PEGylated cationic liposomes as siRNA delivery system[J]. Journal of China Pharmaceutical University, 2011, 42(5): 412-417. |
[10] | Construction of a high epidaunorubicin-producing strain by gene recombination[J]. Journal of China Pharmaceutical University, 2010, 41(3): 283-288. |